A new therapy to re-engage the heart’s natural electrical pathways – instead of bypassing them – could mean more treatment options for heart failure patients who also suffer from electrical disturbances, such as arrhythmias, according to research led by the University of Chicago Medicine.
In a first-ever pilot study, called the His SYNC trial, researchers compared the effectiveness of two different cardiac resynchronization therapies, or treatments to correct irregularities in the heartbeat through implanted pacemakers and defibrillators. The current standard of care, known as biventricular pacing, uses two pacing impulses in both lower chambers, whereas the newer approach, called His bundle pacing, attempts to work toward engaging and restoring the heart’s natural physiology. The two approaches have never before been directly compared in a head-to-head clinical trial.
“This is the first prospective study in our field to compare outcomes between different ways to achieve cardiac resynchronization,” said cardiologist Roderick Tung, MD, FHRS, the Director of Cardiac Electrophysiology & EP Laboratories at the University of Chicago Medicine. “Through His bundle pacing, we’re trying to tap into the normal wiring of the heart and restore conduction the way nature intended. Previously, we have just accepted that we had to bypass it through pacing two ventricles at a time.”
Tung spearheaded the two-year trial with UChicago Medicine cardiologist Gaurav Upadhyay, MD, FHRS, lead author of the study. The trial involved 40 adult patients across seven institutions in the Midwest. The UChicago Medicine team served as the independent coordinating site. Results of the study were presented as a featured late-breaking trial at the Heart Rhythm Society’s annual scientific sessions in San Francisco on May 9. To qualify as a late-breaking trial, the research must be groundbreaking and unique. The study was also published in the Journal of the American College of Cardiology.
A different resynchronization method
Biventricular pacing involves implanting wires, called leads, to simultaneously pace the right and left ventricles of the heart. A pacemaker then sends a timed electric pulse to the two leads with the goal of a synchronized contraction, which closely simulates the heart’s natural heartbeat.
Nevertheless, roughly 30 percent of patients do not respond to biventricular pacing treatment, which has been shown to improve survival in clinical trials.
Tung’s team looked to see if another resynchronization method could help reduce that number by doing a clinical trial comparison between biventricular pacing and His bundle pacing. The latter involves implanting a single lead at the start of the heart’s wiring system, which then naturally branches in two to organically distribute the pacemaker’s electric pulse to both ventricles.
“Permanent His bundle pacing has been around for almost 20 years, but until now there hasn’t been randomized clinical trials on how it compares to biventricular pacing,” Tung said.
For the His SYNC trial, all of the patients met the current guidelines for receiving cardiac resynchronization therapy and were randomly selected to receive either a His bundle pacer or a coronary sinus lead for biventricular pacing. Patients weren’t told which treatment they received.
While the results of the preliminary study did not demonstrate superiority with His-CRT, Tung and his team believe a His bundle pacing approach showed comparable rates of response, warranting further study. The research was limited by a high crossover rate, which was required by the study’s protocol if an adequate lead placement could not be achieved. Nearly half of the patients selected to receive His bundle pacing had to eventually be treated with traditional biventricular pacing due to having a condition called interventricular conduction delay (IVCD). The implantation tools have also not been refined since their introduction 10 years ago.
“We need to learn how to better identify patients who cannot and will not respond to His bundle pacing,” Tung said. “During this pilot study, we learned that the net was cast too wide, and patients with IVCD can’t be corrected and improved by His bundle pacing. His SYNC II, our planned follow-up study, will specifically exclude these patients and this is perhaps the most valuable lesson from the pilot, in addition to estimated treatment effect size.”
In addition, 26 percent of patients chosen to receive biventricular pacing did not, usually because a lead could not be inserted due to the condition of their veins dictated by strict criteria to optimize implantation of left ventricular leads.
Comparing the two approaches
After six months, researchers compared the electrical synchronization and structural function of the two patient groups’ hearts. Although they expected His bundle pacing to be superior, they found no overall significant differences in the two groups, with comparable rates of electrical resynchronization and echocardiographic response.
After one year, there were no differences in the number of hospitalizations or deaths.
Noting the pilot study was limited by its size, Tung says the results indicate further investigation is needed.
“Pilot studies are never meant to be conclusive,” he said. “They’re meant to inform us about effect size, safety and feasibility to help select appropriate patients and power larger studies.”
Learn more: Treatment option to restore natural heartbeat could be on the horizon for heart failure patients
The Latest on: Heart failure
[google_news title=”” keyword=”heart failure” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Heart failure
- Zoo’s beloved orangutan dies following battle with heart diseaseon March 28, 2024 at 12:32 pm
LOUISVILLE, Ky. ( WAVE /Gray News) - The Louisville Zoo shared the sad news that their beloved orangutan, Teak was humanely euthanized following a multi-year battle with heart disease.
- Your favorite chicken sandwich could lead to heart disease, FDA study sayson March 28, 2024 at 11:20 am
According to the CDC, 40% of the sodium consumed by Americans comes from fast food like pizza, tacos and chicken sandwiches.
- Alcohol raises heart disease risk, particularly among womenon March 28, 2024 at 9:34 am
Young to middle-aged women who reported drinking eight or more alcoholic beverages per week—more than one per day, on average—were significantly more likely to develop coronary heart disease compared ...
- New technology could revolutionize valvular heart disease careon March 28, 2024 at 8:19 am
Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number.
- Groundbreaking Study Reveals Hidden Brain Risks in Heart Disease Patientson March 28, 2024 at 6:57 am
Imaging-based detection could facilitate the selection of safer, personalized treatment options. A new analysis involving over 13,000 people has found changes to blood vessels in the brain that can ...
- More than one alcoholic drink a day raises heart disease risk for womenon March 28, 2024 at 6:56 am
The link between alcohol and coronary heart disease proved to be especially strong among women, new research showed.
- A new study says drinking alcohol raises heart disease risk — especially for womenon March 28, 2024 at 5:00 am
Research has linked higher levels of alcohol use to everything from cancer to liver disease, but the messaging around its impact on heart health has been unclear over the past few years. Now there’s ...
- Global Rheumatic Heart Disease Management Industry is expected to surpass US$ 2.04 Billion by 2033, Driven by a strong 4.5% CAGR | FMIon March 28, 2024 at 4:46 am
The Global Rheumatic Heart Disease Management Industry is expected to grow at an impressive rate, reaching a value of US$1.31 billion by 2023. Leading industry experts at Future Industry Insights (FMI ...
- Is intermittent fasting linked to a higher risk of heart disease death? No. Here's why.on March 27, 2024 at 10:01 pm
The headline screamed: “Intermittent fasting linked to a higher risk of heart disease death.” To say I was stunned at this headline is an understatement. How could intermittent fasting, a highly ...
- Heart disease, stroke risk may be higher in certain neighborhoodson March 27, 2024 at 8:34 am
People living in neighborhoods with high rates of environmental and socioeconomic problems may face a higher risk for heart disease and double the risk for stroke, new research finds.
via Bing News